Gilead Sciences (GILD) rates highest in fundamental analysis, earning a 100% rating

From Nasdaq: 2025-05-30 10:08:00

Validea’s guru fundamental report for Gilead Sciences Inc. (GILD) shows that it rates highest using the Twin Momentum Investor model by Dashan Huang. GILD is a large-cap growth stock in the Biotechnology & Drugs industry, with a 100% rating based on fundamental momentum and price momentum. Dashan Huang, an Assistant Professor of Finance, identified seven fundamental variables that, when combined with price momentum, led to market outperformance. GILD passes the fundamental momentum and twelve minus one momentum tests, earning a final rank of pass. Validea follows the strategies of investment legends like Warren Buffett and Peter Lynch for stock analysis and model portfolios.



Read more at Nasdaq: Validea Detailed Fundamental Analysis – GILD